(A) The expression of CD73, CD90, and CD105 (positive biomarkers), and lack of expression of CD34, CD19, CD14, HLA-DR (negative biomarkers) was assessed by flow cytometry in every sample at passage 2. CD44, a marker for pluripotency highly conserved across species, was included in the evaluation. In all the samples tested and used for this study, >95% of the cells expressed the positive and <5% expressed the negative biomarkers. Representative example (black histograms) with negative controls (unstained samples -grey histograms).
